Biblio
Advances in the ocular complications after hematopoietic stem cell transplantation. Ann Hematol. 2024.
. Single-Center Retrospective Clinical Evaluation of Venetoclax Combined with HMAs and Half-Dose CAG for Unfit or Refractory/Relapsed AML. Onco Targets Ther. 2023;16:409-419.
.